Qiu X, He H, Zeng H, Tong X, Zhang C, Liu Y, Liao Z, Liu Q. Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration. Genes Dis. 2024;11:101004.

Article  CAS  PubMed  Google Scholar 

Xiang S, Li J, Shen J, Zhao Y, Wu X, Li M, Yang X, Kaboli PJ, Du F, Zheng Y, Wen Q, Cho CH, Yi T, Xiao Z. Identification of prognostic genes in the tumor microenvironment of hepatocellular carcinoma. Front Immunol. 2021;12:653836.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruf B, Heinrich B, Greten TF. Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells. Cell Mol Immunol. 2021;18:112–27.

Article  CAS  PubMed  Google Scholar 

Bagchi S, Yuan R, Engleman EG. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol. 2021;16:223–49.

Article  CAS  PubMed  Google Scholar 

Johnstone TB, Agarwal SR, Harvey RD, Ostrom RS. cAMP signaling compartmentation: adenylyl cyclases as anchors of dynamic signaling complexes. Mol Pharmacol. 2018;93:270–6.

Article  CAS  PubMed  Google Scholar 

Chen R, Zeng L, Zhu S, Liu J, Zeh HJ, Kroemer G, Wang H, Billiar TR, Jiang J, Tang D, Kang R. cAMP metabolism controls caspase-11 inflammasome activation and pyroptosis in sepsis. Sci Adv. 2019;5:eaav5562.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie Y, Wu H, Hu W, Zhang H, Li A, Zhang Z, Ren S, Zhang X. Identification of hub genes of lung adenocarcinoma based on weighted gene co-expression network in Chinese population. Pathol Oncol Res. 2022;28:1610455.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mao XH, Ye Q, Zhang GB, Jiang JY, Zhao HY, Shao YF, Ye ZQ, Xuan ZX, Huang P. Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer. World J Surg Oncol. 2021;19:29.

Article  PubMed  PubMed Central  Google Scholar 

Wang Q, Liu W, Zhang S, Liang Z, Jiang L, Xue A, Cen X, Bu Q. Combined transcriptomic and lipidomic analysis reveals aberrant lipid metabolism in central nervous system hemangioblastomas. Sci Rep. 2021;11:1314.

Article  PubMed  PubMed Central  Google Scholar 

Lu MY, Liu TW, Liang PC, Huang CI, Tsai YS, Tsai PC, Ko YM, Wang WH, Lin CC, Chen KY, Wang SC, Wei YJ, Hsu PY, Jang TY, Hsieh MY, Wang CW, Yeh ML, Lin ZY, Huang CF, Huang JF, Dai CY, Chuang WL, Yu ML. Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradication. Am J Cancer Res. 2023;13:190–203.

CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Xiong Y, Zhao L, Gu K, Li Y, Zhao F, Li J, Wang M, Wang H, Tao Z, Wu T, Zheng Y, Li X, Liu XS. UCSCXenaShiny: an R/CRAN package for interactive analysis of UCSC Xena data. Bioinformatics. 2022;38:527–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li C, Tang Z, Zhang W, Ye Z, Liu F. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021;49:W242–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu CJ, Hu FF, Xie GY, Miao YR, Li XW, Zeng Y, Guo AY. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2023;24:1–10.

Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, Maitland A, Mostafavi S, Montojo J, Shao Q, Wright G, Bader GD, Morris Q. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:W214–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, Bork P, Jensen LJ, von Mering C. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang H, Liu Y, Liu J, Chen J, Wang J, Hua H, Jiang Y. cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment. J Hematol Oncol. 2024;17:5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roy D, Balasubramanian S, Krishnamurthy PT, Sola P, Rymbai E. Phosphodiesterase-4 inhibition in Parkinson’s disease: molecular insights and therapeutic potential. Cell Mol Neurobiol. 2023;43:2713–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chung JH, Choi HJ, Kang YJ, Kim YS, Lee SY, Kwon RJ, Jeong HS, Park SJ, Jeong Y, Kang D, Ko J, Noh S, Chung HY, Moon HR, Yoon SH. MHY4571, a novel diarylcyclohexanone derivative, exerts anti-cancer activity by regulating the PKA-cAMP-response element-binding protein pathway in squamous cell lung cancer. Exp Hematol Oncol. 2022;11:68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang H, Kong Q, Wang J, Jiang Y, Hua H. Complex roles of cAMP-PKA-CREB signaling in cancer. Exp Hematol Oncol. 2020;9:32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pierre S, Eschenhagen T, Geisslinger G, Scholich K. Capturing adenylyl cyclases as potential drug targets. Nat Rev Drug Discov. 2009;8:321–35.

Article  CAS  PubMed  Google Scholar 

Sabbatini ME, Gorelick F, Glaser S. Adenylyl cyclases in the digestive system. Cell Signal. 2014;26:1173–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanchez-Collado J, Lopez JJ, Jardin I, Salido GM, Rosado JA. Cross-talk between the adenylyl cyclase/cAMP pathway and Ca(2+) homeostasis. Rev Physiol Biochem Pharmacol. 2021;179:73–116.

Article  CAS  PubMed  Google Scholar 

Wang W, Chen QY, Zhao P, Zhong J, Wang Y, Li X, Zhuo M, Chen X. Human safety study of a selective neuronal adenylate cyclase 1 inhibitor NB001 which relieves the neuropathic pain and blocks ACC in adult mice. Mol Pain. 2022;18:17448069221089596.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johann K, Bohn T, Shahneh F, Luther N, Birke A, Jaurich H, Helm M, Klein M, Raker VK, Bopp T, Barz M, Becker C. Therapeutic melanoma inhibition by local micelle-mediated cyclic nucleotide repression. Nat Commun. 2021;12:5981.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan G, Huang M, Fu S, Wang Y, He L, Wu B, Yang J, Lin S, Fan Y. ADCY4 inhibits cAMP-induced growth of breast cancer by inactivating FAK/AKT and ERK signaling but is frequently silenced by DNA methylation. Sci Rep. 2025;15:20426.

Article  PubMed  PubMed Central  Google Scholar 

Haghshenas Z, Fathi S, Ahmadzadeh A, Nazari E. Identification of BCL11A, NTN5, and OGN as diagnosis biomarker of papillary renal cell carcinomas by bioinformatic analysis. J Kidney Cancer VHL. 2025;12:12–22.

Article  PubMed  PubMed Central  Google Scholar 

Bruno R, Poma AM, Ali G, Distefano C, Proietti A, Chella A, Lucchi M, Melfi F, Franco R, Fontanini G. Gene expression analysis of biphasic pleural mesothelioma: new potential diagnostic and prognostic markers. Diagnostics (Basel). 2022;12:1–12.

Gil GP, Ananina G, Maschietto M, Lima SCS, da Silva Costa SM, Baptista LC, Ito MT, Costa FF, Costa ML, de Melo MB. Epigenetic analysis in placentas from sickle cell disease patients reveals a hypermethylation profile. PLoS ONE 2022;17:1–23.

Fan Y, Mu J, Huang M, Imani S, Wang Y, Lin S, Fan J, Wen Q. Epigenetic identification of ADCY4 as a biomarker for breast cancer: an integrated analysis of adenylate cyclases. Epigenomics. 2019;11:1561–79.

Article  CAS  PubMed  Google Scholar 

Zhong X, Ming Z, He H, Xiong Y, Wang S, Xia Q. A highly sensitive methylation assay for prostate cancer diagnosis. World J Mens Health. 2026; 44:18–128.

Brito-Rocha T, Constancio V, Leite-Silva P, Carvalho-Maia C, Sequeira JP, Salta S, Lobo J, Machado DI, Nunes SP, Silva-Santos R, Freitas R, Goncalves Dias C, Vieira C, Soares M, Henrique R, Jeronimo C. Multi-cancer early detection via a DNA methylation multiplex ddPCR-based blood test. Int J Cancer. 2025;157:1006–19.

Article